₹ 0.0 Cr
Volume transacted
0.0 K
stocks traded
Last Updated time: 26 Jul 09:08 AM
Kopran Ltd
NSE: KOPRAN
DPS
₹ 3
Last updated : FY 2023
The Dividend per Share of Kopran Ltd is ₹ 3 as of 2023 .a1#The Dividend Payout of Kopran Ltd changed from 55.28 % on March 2019 to 46.28 % on March 2023 . This represents a CAGR of -5.75% over 3 years. a1#The Latest Trading Price of Kopran Ltd is ₹ 259.75 as of 26 Jul 09:00 .a1#The Market Cap of Kopran Ltd changed from ₹ 179.93 crore on March 2019 to ₹ 532.49 crore on March 2023 . This represents a CAGR of 24.23% over 5 years. a1#The Revenue of Kopran Ltd changed from ₹ 126.27 crore to ₹ 195.75 crore over 8 quarters. This represents a CAGR of 24.51% a1#The EBITDA of Kopran Ltd changed from ₹ 13.8 crore to ₹ 31.36 crore over 8 quarters. This represents a CAGR of 50.75% a1#The Net Pr of Kopran Ltd changed from ₹ 7.6 crore to ₹ 18.62 crore over 8 quarters. This represents a CAGR of 56.52% a1#
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Market Cap
₹ 1,245 Cr
EPS
₹ 10.6
P/E Ratio (TTM) *
24.4
P/B Ratio (TTM) *
2.5
DTE *
0.2
ROE *
10.4
ROCE *
12.9
Dividend Yield *
2.72
DPS *
3
Dividend Payout *
46.28
Ann.Dividend % *
30
* All values are consolidated
Last Updated time: 26 Jul 09:08 AM
* All values are consolidated
Last Updated time: 26 Jul 09:08 AM
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Period | |
---|---|
Mar '19 | 0 |
Mar '20 | 0 |
Mar '21 | 55 |
Mar '22 | 123 |
Mar '23 | 46 |
* All values are a in %
Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.
* All values are in %
Kopran Ltd
NSE: KOPRAN
PRICE
₹ 259.75
1.40 (0.54%)
Last updated : 26 Jul 09:00
Strength
3
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.
A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.
Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.
A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Period | |
---|---|
Mar '19 | 180 |
Mar '20 | 110 |
Mar '21 | 454 |
Mar '22 | 1357 |
Mar '23 | 532 |
* All values are a in ₹crore
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Period | |
---|---|
Jun '22 | 126 |
Sep '22 | 117 |
Dec '22 | 160 |
Mar '23 | 153 |
Jun '23 | 119 |
Sep '23 | 153 |
Dec '23 | 161 |
Mar '24 | 196 |
* All values are a in ₹crore
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Period | |
---|---|
Jun '22 | 14 |
Sep '22 | 11 |
Dec '22 | 15 |
Mar '23 | 16 |
Jun '23 | 9 |
Sep '23 | 23 |
Dec '23 | 26 |
Mar '24 | 31 |
* All values are a in ₹crore
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Period | |
---|---|
Jun '22 | 8 |
Sep '22 | 5 |
Dec '22 | 7 |
Mar '23 | 8 |
Jun '23 | 3 |
Sep '23 | 14 |
Dec '23 | 16 |
Mar '24 | 19 |
* All values are a in ₹crore
Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment. It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin. Kopran also makes penicillin-G acylase, an enzyme made through fermentation. It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities. In 1995, the company was awarded the Quality Excellence award by the Indian Drug Manufacturers Association. Kopran's high growth rate in exports has been recognised by a number of awards from CHEMEXCIL and the Ministry of Commerce. The company launched new products like AZ-1 Caps, Klodip Tabs, Moclox Kid Tabs, Amyn Kid Tabs, Tini-NF, Amyn Caps and Amyn Dry Syrup. Kopran entered into a joint venture with M/s Industrial Promotion Services Ltd to take over a running unit viz Kampala Pharmaceuticals Industries Ltd in Uganda. The company has been ranked as amongst the top few fastest growing companies in India(ORG Marg-June 2000). It closed down its manufacturing facility at Saki Naka, Andheri, Bombay. Globalpharma, a joint venture with Dubai Investments Corporation started commercial production in the first quarter of 2002. The company has increased its installed capacity of Liquids by 3.00 lakhs of Litres during 2001 and consequent of this capacity expansion the total installed capacity has gone up to 12.00 lakhs of Litres. The company has also increased its installed capacity of Tablets & Capsules by 270 crores(Nos) and the total capacity has gone up to 1080 crores(Nos). In Feb. 2001, Kopran tied up with E-Merck for co-marketing a new anti-inflammatory drug, Rofecoxib, in India. Rofecoxib is one of the fast-moving non-steroid anti-inflammatory drugs (NSAID),has been launched in the international market. The Company also launched Cholestat (Atorvastatin - a cholesterol reducer) and further gave co-marketing rights for Atorvastatin to E-Merck (India). The company had launched new products in therapeutic groups like Asthma,Cardiology,Diabetes and Lifestyle products during 2003.The company has obtained approval from European Directorate for Quality of Medicines(EDQM) in September 2003. Upgradation of Formulation Manufacturing facility took place to meet with the latest International Regulatory Norms.The United Kingdom Medicines and Healthcare Products Regulatory Agency(UK MHRA) is expected to inspect the facilities in the first quarter of 2004. Kopran Pharmaceuticals Ltd., the Company marketing the SMYLE brand of products was merged into the Company effective from 1st March, 2005. The Company introduced two new bulk drugs viz. Pregabalin and Cefditorin during the year 2007. The Company during the FY 2014-15 sold the Active Pharmaceuticals Ingredients (API) business on slump sale basis to its subsidiary Kopran Research Laboratories Ltd. at a consideration of Rs 110 Crores on 30th March, 2015. Similarly, the Consumer Care Division was sold w.e.f 1 April 2015.
Kopran schedules board meeting
Kopran will hold a meeting of the Board of Directors of the Company on 8 August 2024. Powe...
Read more
24 Jul 202409:33
Kopran schedules AGM
Kopran announced that the 65th Annual General Meeting(AGM) of the company will be held on ...
Read more
16 May 202416:32
Board of Kopran recommends Final Dividend
Kopran announced that the Board of Directors of the Company at its meeting held on 16 May ...
Read more
16 May 202414:23
Kopran to announce Quarterly Result
Kopran will hold a meeting of the Board of Directors of the Company on 16 May 2024 Powered...
Read more
08 May 202416:09
Kopran to announce Quarterly Result
Kopran will hold a meeting of the Board of Directors of the Company on 7 February 2024. Po...
Read more
23 Jan 202416:22
Kopran to conduct board meeting
Kopran will hold a meeting of the Board of Directors of the Company on 7 November 2023. Po...
Read more
27 Oct 202316:52
FAQs for dividends of Kopran Ltd
What is the current market price of Kopran Ltd Ltd as of July 26, 2024?
What dividend did Kopran Ltd declare in the last fiscal year?
What is the most recent dividend declared by Kopran Ltd?
How many times has Kopran Ltd declared dividends in the current fiscal year
How many times did Kopran Ltd declare dividends in the previous fiscal year?
Unlimited trading at just
Rs. 199